Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Efficacy Study of Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

NCT04540588 is registered in ClinicalTrials.gov with Alpha Tau Medical LTD. as lead sponsor.

NCT NCT04540588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04540588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Efficacy Study of Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Lead sponsor
Alpha Tau Medical LTD.
Phase
Not applicable
Overall status
Completed
Start date
December 22, 2020
Completion date
December 1, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucosal neoplasm of oral cavity, skin cancer, soft tissue neoplasm